// App-Quantinova.ai

: NONHEMATOLOGIC TOXICITY OF IMATINIB MESYLATE IN PEDIATRIC PATIENT WITH PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT

Researchers

Presenter

  • Pio Stellato

Principal Investigators

  • Antonia De Matteo

  • Fara Petruzziello

  • Giuliana Beneduce

  • Giovanna Giagnuolo

  • Marta Raimondo

  • Giovanna Paolo

  • Giuseppina Aloj

  • Rosanna Parasole

  • Giuseppe Menna

Medical Centers

  • Pediatric onco-hematology,AORN Santobono-Pausilipon,Naples,Italy

  • Translational Medical Science - Pediatric Section,AOU Federico II,Naples,Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Thrombocytopenia

  • Ascending cholangitis

  • Anemia

Biomarkers

  • N-Acylethanolamine acid amidase

  • Breakpoint Cluster Region

  • D-dimer

Drug/Treatment

  • Imatinib

  • Tranexamic acid

  • Caprilon

  • Fibrinogen (IV)

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved